Latest financial market updates and expert analysis
Analysis The numbers are stark. In its second week on the market, Eli Lilly’s new oral obesity pill Foundayo generated just 3,707 prescriptions. By comparison, Novo Nordisk’s oral Wegovy racked up...
The oil market is contending with a supply crisis not seen in modern history. The Strait of Hormuz, a chokepoint...
The numbers coming out of Micron Technology are staggering enough to command attention on their own. But behind the scenes...
The VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF is hovering just below its 52-week high, with a fresh dividend...
The stars are not aligning for Barrick Mining. While the Canadian gold giant posted a near-$5 billion profit last year...
The German biotech is making headlines on two fronts this week — one that underscores its long-term oncology ambitions, and...
The stock has clawed back some ground since last week’s 18% rout, but the tension between strong operational performance and...
The weight-loss drug market is turning into a battlefield, and Hims & Hers finds itself caught between pharmaceutical giants, deep-pocketed...
The Australian Securities Exchange has suspended trading in European Lithium shares after media reports surfaced suggesting a potential change of...
Netflix is navigating one of its most eventful periods in years, balancing a massive share buyback, a leadership transition, and...
The numbers coming out of Oracle are almost too big to process. A $553 billion backlog of contracted revenue, a...
